1. Medchemcomm. 2016 Nov 1;7(11):2076-2082. doi: 10.1039/C6MD00371K. Epub 2016
Oct  5.

Improved Antiviral Activity of a Polyamide Against High-Risk Human 
Papillomavirus Via N-Terminal Guanidinium Substitution.

Castaneda CH(1), Scuderi MJ(1), Edwards TG(1), Harris GD Jr(1), Dupureur CM(1), 
Koeller KJ(1), Fisher C(2), Bashkin JK(3).

Author information:
(1)Department of Chemistry & Biochemistry, University of Missouri-St. Louis, St. 
Louis, MO 63121, USA.
(2)NanoVir, LLC, Kalamazoo, MI 49008 (USA).
(3)Department of Chemistry & Biochemistry, University of Missouri-St. Louis, St. 
Louis, MO 63121, USA; NanoVir, LLC, Kalamazoo, MI 49008 (USA).

We report the synthesis of two novel pyrrole-imidazole polyamides with 
N-terminal guanidinium or tetramethylguanidinium groups and evaluate their 
antiviral activity against three cancer-causing human papillomavirus strains. 
Introduction of guanidinium improves antiviral activity when compared to an 
unsubstituted analog, especially in IC90 values. These substitutions change 
DNA-binding preferences, while binding affinity remains unchanged.

DOI: 10.1039/C6MD00371K
PMCID: PMC5101016
PMID: 27840672

Conflict of interest statement: Â§The authors declare no competing interests.